Kenichi Horinouchi

545 total citations
7 papers, 448 citations indexed

About

Kenichi Horinouchi is a scholar working on Epidemiology, Hematology and Physiology. According to data from OpenAlex, Kenichi Horinouchi has authored 7 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Hematology and 3 papers in Physiology. Recurrent topics in Kenichi Horinouchi's work include Cytomegalovirus and herpesvirus research (3 papers), Lysosomal Storage Disorders Research (3 papers) and Biochemical and Molecular Research (2 papers). Kenichi Horinouchi is often cited by papers focused on Cytomegalovirus and herpesvirus research (3 papers), Lysosomal Storage Disorders Research (3 papers) and Biochemical and Molecular Research (2 papers). Kenichi Horinouchi collaborates with scholars based in Japan, United States and Germany. Kenichi Horinouchi's co-authors include Edward H. Schuchman, Konrad Sandhoff, Colin L. Stewart, Charles L. Bisgaier, Daniel P. Perl, Klaus Ferlinz, Robert J. Desnick, Shai Erlich, Takeshi Sakiyama and Takahiro Tokudome and has published in prestigious journals such as Nature Genetics, Thrombosis and Haemostasis and Human Pathology.

In The Last Decade

Kenichi Horinouchi

7 papers receiving 439 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenichi Horinouchi Japan 4 316 208 89 65 57 7 448
Marie‐Thérèse Vanier France 11 335 1.1× 361 1.7× 169 1.9× 38 0.6× 36 0.6× 17 641
Nina Aula Finland 8 258 0.8× 353 1.7× 208 2.3× 59 0.9× 20 0.4× 10 616
Ladislav Kuchař Czechia 11 192 0.6× 182 0.9× 87 1.0× 28 0.4× 39 0.7× 25 376
Roscoe O. Brady United States 10 317 1.0× 426 2.0× 164 1.8× 38 0.6× 31 0.5× 10 713
Jennifer A. Wiseman United States 8 216 0.7× 383 1.8× 212 2.4× 100 1.5× 27 0.5× 9 553
Mukarram El-Banna United States 7 217 0.7× 412 2.0× 222 2.5× 104 1.6× 28 0.5× 8 571
Maja Di Rocco Italy 12 212 0.7× 131 0.6× 71 0.8× 48 0.7× 18 0.3× 20 459
Kyle Peake Canada 11 173 0.5× 355 1.7× 106 1.2× 95 1.5× 37 0.6× 15 582
Annette Bley Germany 14 500 1.6× 349 1.7× 79 0.9× 33 0.5× 68 1.2× 29 816
Teresa Pàmpols Spain 12 459 1.5× 267 1.3× 151 1.7× 40 0.6× 42 0.7× 27 640

Countries citing papers authored by Kenichi Horinouchi

Since Specialization
Citations

This map shows the geographic impact of Kenichi Horinouchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenichi Horinouchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenichi Horinouchi more than expected).

Fields of papers citing papers by Kenichi Horinouchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenichi Horinouchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenichi Horinouchi. The network helps show where Kenichi Horinouchi may publish in the future.

Co-authorship network of co-authors of Kenichi Horinouchi

This figure shows the co-authorship network connecting the top 25 collaborators of Kenichi Horinouchi. A scholar is included among the top collaborators of Kenichi Horinouchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenichi Horinouchi. Kenichi Horinouchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Tsuda, M., Kenichi Horinouchi, Takeshi Sakiyama, & Misao Ōwada. (2002). Novel missense mutation in the purine nucleoside phosphorylase gene in a Japanese patient with purine nucleoside phosphorylase deficiency. Pediatrics International. 44(3). 333–334. 2 indexed citations
2.
Horinouchi, Kenichi, et al.. (2001). A Novel Nonsense Mutation in the Antithrombin III Gene (Ser365 to Stop) Causing Deep and Mesenteric Venous Thromboses. Thrombosis and Haemostasis. 85(3). 570–571. 3 indexed citations
3.
Takahashi, Tsutomu, Kenji Akiyama, Takahiro Tokudome, et al.. (1997). Heterogeneity of liver disorder in type B niemann-pick disease. Human Pathology. 28(3). 385–388. 19 indexed citations
4.
Horinouchi, Kenichi, Shai Erlich, Daniel P. Perl, et al.. (1995). Acid sphingomyelinase deficient mice: a model of types A and B Niemann–Pick disease. Nature Genetics. 10(3). 288–293. 410 indexed citations
5.
Horinouchi, Kenichi, Takeshi Sakiyama, Lygia V. Pereira, P.A. Lalley, & Edward H. Schuchman. (1993). Mouse Models of Niemann-Pick Disease: Mutation Analysis and Chromosomal Mapping Rule Out the Type A and B Forms. Genomics. 18(2). 450–451. 8 indexed citations
6.
Sakiyama, Takeshi, M. Tsuda, Kenichi Horinouchi, et al.. (1992). Study of bone marrow tranplantation for Niemann‐Pick mice using Sry and Zfy genes. Journal of Inherited Metabolic Disease. 15(5). 821–826. 2 indexed citations
7.
Sakiyama, Takeshi, Kenichi Horinouchi, Akira Akatsuka, et al.. (1989). Clinico-Biochemical and Molecular Studies of Purine Nucleoside Phosphorylase Deficiency. Advances in experimental medicine and biology. 253A. 73–79. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026